Tarbox Family Office, Inc. Biogen Inc. Transaction History

Tarbox Family Office, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$187.54 - $223.02 $15,565 - $18,510	-83 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$193.77 - $244.14 $6,781 - $8,544	-35 Reduced 29.66%	83 $17,000
Q4 2021 Jan 06, 2022	BUY	$223.92 - $287.77 $4,926 - $6,330	22 Added 22.92%	118 $28,000
Q3 2021 Oct 12, 2021	SELL	$282.99 - $369.05 $5,093 - $6,642	-18 Reduced 15.79%	96 $27,000
Q2 2021 Jul 16, 2021	BUY	$259.0 - $414.71 $4,662 - $7,464	18 Added 18.75%	114 $39,000
Q4 2020 Jan 27, 2021	SELL	$236.26 - $355.63 $8,032 - $12,091	-34 Reduced 26.15%	96 $24,000
Q3 2020 Oct 22, 2020	BUY	$264.77 - $305.71 $8,472 - $9,782	32 Added 32.65%	130 $37,000
Q2 2020 Jul 23, 2020	SELL	$258.66 - $342.55 $10,863 - $14,387	-42 Reduced 30.0%	98 $26,000
Q1 2020 Apr 30, 2020	BUY	$268.85 - $341.04 $4,570 - $5,797	17 Added 13.82%	140 $44,000
Q4 2019 Jan 31, 2020	BUY	$220.06 - $304.07 $3,741 - $5,169	17 Added 16.04%	123 $36,000
Q2 2019 Aug 02, 2019	BUY	$219.29 - $241.72 $3,947 - $4,350	18 Added 20.45%	106 $25,000
Q1 2019 Apr 24, 2019	SELL	$216.71 - $338.96 $4,767 - $7,457	-22 Reduced 20.0%	88 $21,000
Q3 2017 Oct 19, 2017	BUY	$281.15 - $329.69 $30,926 - $36,265	110	110 $34,000

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.